"Pre-Exposure" HIV Prophylaxis (PrEP) Is A Growing Cult In AIDS World: Activists Made Facebook Remove Ads About Class Action Lawsuits, It's Pushed On Heterosexuals And Children Are Next

Rebecca Culshaw Smith PhD Was Once Employed By AIDS Inc; Now She Exposes The Cult, With A Particular Focus On One Of The Darkest Chapters In "Medicine." It's actually Post-Kinsey-an Sexual Engineering

There is a story beast of enormous proportions unfolding, and one writer has been following its tracks since the beginning. The “HIV Causes AIDS” algorithm spawns infinite “treatment” hallucinations, driven by a mania to “eradicate” the “virus,” no matter the toxic devastation to the body.

After the AZT dark age, came the “cocktail” therapy (multiple drugs taken in infinite combinations) era, followed by the one nobody ever anticipated: PrEP. That jarring acronym is itself an esoteric Pharma-cult, spawning the return of condom-free “safer” sex, initially for gay men, now for everybody, including heterosexuals and even children.

Like the pill for women, it is tied to sexual “liberation” promising that if taken daily, and correctly, it can prevent HIV sero-conversion even for the highly sexually active. It’s composed of two highly toxic HIV drugs, and it’s given as either pills or injections. It is a kind of chemical internal condom, doubling as a vaccine, and a way of life, pride, and liberty. It swept the gay and LGBTQ communities over a decade ago as a final solution for the problem of how to maintain maniacal emphasis on sex while calling it “safe,” “safer” and “life-saving.”

The writer in question, who’s been tracking PrEP’s deadly course is also a PhD mathematician, and author, is Rebecca Culshaw Smith, author of The Real AIDS Epidemic: How The Tragic HIV Mistake Threatens Us All (Skyhorse, 2023.) She wrote about the expansion of PrEP to children (not sure what age but in the link above, the promoters of it themselves use the word “children,”) on her Substack recently, here. And Neenah Ostrom covered Culshaw Smith’s scoop of the NYT (by years) here.

PrEP causes bone loss, osteoporosis, kidney failure, and in some cases death; there are massive class action lawsuits pending, ads for which which LBGTQ activists got banned from Facebook. They have also tried to de-platform Culshaw-Smith’s recent book, by issuing one of their standard fare tantrums, including in threatening letters to the book’s distributors. They failed. It fascinates me that these people think they still dictate the culture, journalism and publishing, years after they and their leader, Anthony Fauci, have been fully and finally exposed by Fauci nemesis Robert F. Kennedy Jr., who summed up the true history in his smash book The Real Anthony Fauci, which has sold over 1.1 million copies to date.

Here’s a dystopian, creepy PrEPcommercial from Australia, featuring the lucky people who take PReP drawn with stubs for arms. (Can somebody explain the graphic design ethos of late that always features people without hands, feet, and facial features?)

It’s all about…

SEX.

Who sees the pattern?

And here, cut and pasted, is Culshaw Smith’s latest report on Truvada-gate, and a limited hangout piece from the usual suspects at The New York Times. Naturally, brother of Epstein collaborator Jes Staley, TAG Activist Peter Staley, is quoted, with his usual boasting and reality denial. Here is is calling Anthony Fauci a great scientist, and lamenting “denialism,” and “witch-hunts” against “science,” while he continues to push every lethal Pharma agenda under the sun, and, of course, our “support” of Ukraine.

Here’s a Truvada commercial playing on the theme: “I’m On The Pill.”

”Thinking about sex? Think about PrEp.” (Original, and news report.)

“Freddie” combines HIV pharma profit with a to-your-door delivery service. This ad also implies sex with the guy who makes the delivery. Both men have extremely dead eyes, in this ad, promoting not only PrEP but sex with total strangers.

Ok, one more:

A gay friend told me wearily about three years ago that in LA where he lives, PrEP is gospel, it’s more than a “choice,” it’s simply a given, for sexually active gay men.

“Everybody’s on it. It’s like recycling,” he said. “It’s a way to help save the planet.”

Except for those whose kidneys fail, whose bones break, and whose lives are destroyed. Or, who die.

I rarely have it in me to look at this AIDS cult stuff anymore, it is so very distressing—mass medication of healthy HIV negative people— but I am grateful for Culshaw Smith’s ongoing work about these very important class action lawsuits. She worked on the inside of AIDS Inc, as an HIV mathematician, and defected, publicly, with the predictable detonation of her professional life.

I know if no cult more asphyxiating, dishonest, or deadly than the HIV/AIDS cult. The cult’s core faith is that there is no “treatment” protocol, no drug regimen, too toxic to be worshipped and violently defended. The cult is both sadistic and masochistic. You will never understand them, decode their logic, never get them to face what horrors by toxic drugs they ushered in, and never get them to be interested in other people’s right to think differently and still be employed.

And what was it all about, then?

It appears the great revolution with all its toxic massacres, trauma based mind control, wrecked lives, suicides, families shattered, destroyed careers, and infinite other losses, culminated in… some people’s triumphant right to once again have limitless sex be the only meaning of life, along with…dance clubs?

Was that it?

I guess that’s why it all had to go down the way it did.

I could never work out how they (AIDS activists/professionals) were so privileged and elect, as to have the entire pharmaceutical industry, medical industrial complex, Hollywood, media, advertising, NGOs, Congress,—all pinwheeling around how to make sure they got to do precisely what they wanted to do. Who else gets that?

The sexually relentless are the rulers of the culture.

PrEP is their chemical deity.

Though no AZT death lawsuit ever made it, the Truvada lawsuits seem to have a good chance.

Incidentally, here’s the most comprehensive study on “transmission” of “HIV” over 10 years, between hundreds of couples “practicing” “unsafe sex—” the famous Padian Report. How many sero-conversions did she find, after 10 years, among “seri-discordant” couples? Zero. Not one.

Here’s Culshaw Smith’s latest piece on “The Truvada Disaster” and damage control at the most boring newspaper in the world:

The Truvada Disaster made the New York Times.

REBECCA CULSHAW SMITH

JUL 22

SHARE

After years of flying (mostly) under the radar in the legacy media, Gilead’s dirty tricks have made the New York Times, in a piece written by Rebecca Robbins and Sheryl Gay Stolberg.

The timing of this article is interesting; moreover, recall the attempts on the parts of AIDS activists to censor the advertisements for the Truvada lawsuits—effectively, intentionally hiding the dangers of Truvada from patients, and attempting to steer them away from any idea that they might be entitled to compensation for their pain and suffering. This piece in the NYT is an interesting development in light of these mostly successful censorship attempts.

Thanks for reading The Real AIDS Epidemic! Subscribe for free to receive new posts and support my work.

Pledge your support

Consider the following excerpts:

In 2004, Gilead Sciences decided to stop pursuing a new H.I.V. drug. The public explanation was that it wasn’t sufficiently different from an existing treatment to warrant further development.

In private, though, something else was at play. Gilead had devised a plan to delay the new drug’s release to maximize profits, even though executives had reason to believe it might turn out to be safer for patients, according to a trove of internal documents made public in litigation against the company.

The delayed release of the new treatment is now the subject of state and federal lawsuits in which some 26,000 patients who took Gilead’s older H.I.V. drugs claim that the company unnecessarily exposed them to kidney and bone problems.

Just a few months ago, the number was 23,000.

Today, a generation of expensive Gilead drugs containing the new iteration of tenofovir account for half of the market for H.I.V. treatment and prevention, according to IQVIA, an industry data provider. One widely used product, Descovy, has a sticker price of $26,000 annually. Generic versions of its predecessor, Truvada, whose patents have expired, now cost less than $400 a year.

Here is just one story of a man who was harmed by TDF:

David Swisher, who lives in Central Florida, is one of the plaintiffs suing Gilead in federal court. He took Truvada for 12 years, starting in 2004, and developed kidney disease and osteoporosis. Four years ago, when he was 62, he said, his doctor told him he had “the bones of a 90-year-old woman.”

It was not until 2016, when Descovy was finally on the market, that Mr. Swisher switched off Truvada, which he believed was harming him. By that time, he said, he had grown too sick to work and had retired from his job as an airline operations manager.

“I feel like that whole time was taken away from me,” he said.

In 2001, the Food and Drug Administration for the first time approved a product containing Gilead’s first iteration of tenofovir. Four more would follow. The drugs prevent the replication of H.I.V., the virus that causes AIDS.

Those became game-changers in the fight against AIDS, credited with saving millions of lives worldwide. The drugs came to be used not only as a treatment but also as a prophylactic for those at risk of getting infected.

But a small percentage of patients who were taking the drug to treat H.I.V. developed kidney and bone problems. It proved especially risky when combined with booster drugs to enhance its effectiveness — a practice that was once common but has since fallen out of favor. The World Health Organization and the U.S. National Institutes of Healthdiscourage the use of the original version of tenofovir in people with brittle bones or kidney disease.

The newer version doesn’t cause those problems, but it can cause weight gain and elevated cholesterol levels. For most people, experts say, the two tenofovir-based drugs — the first known as T.D.F., the second called T.A.F. — offer roughly equal risks and benefits.

A “small percentage of patients”? 26,000 plaintiffs represent 2.1% of the US HIV positive population, and those are only the victims we know about.

Gilead moved to resurrect the newer formulation in 2010, putting it on track for its 2015 release. John Milligan, Gilead’s president and future chief executive, told investors that it would be a “kinder, gentler version” of tenofovir.

A “kinder, gentler” version of a toxic drug? Where have we seen this before?

Furthermore, weight gain and elevated cholesterol levels are not the only adverse effects of TAF, according to the law firm Shouse Law, who is involved in litigation regarding Genvoya, a TAF based drug, alleging that it causes “bone loss, osteoporosis, kidney failure, and lactic acidosis”—the exact same adverse effects reported for TDF.

Here are a few Twitter reactions to the NYT piece:

From Toxic poz-itivity:

I actually know people who had to get off of the Truvada iteration of PrEP because of liver damage. There was one guy I know who had bone damage from it. It's maddening to know there was a safer alternative the whole time but capitalism...

From Mike:

I developed Stage 3 kidney disease after taking #Truvada from 2008-14 so was surprised when it became popular for Prep. The graph of my declining kidney function pointed to, and was the reason I was taken off, Truvada. Now I’ve gone from 6’-0” to 5’-10” in 2 years. What’s next?

From LIVE WORK PLAY DANCE

My husband had kidney failure taking Truvada for just a couple of weeks and ended up on dialysis for over a year in 2005. No lawyer would take the case and this just infuriates me to no end. Now, the truth comes out. Remember, these drugs were developed with federal dollars.

Finally, consider the Twitter reaction by AIDS activist Peter Staley:

We may have lost the generic Truvada pay-for-delay case against @GileadSciences, but our discovery process proved we were right that Gilead harmed thousands of people with HIV just to patent hop.

In light of the attempts to censor any advertisements for the Truvada lawsuits, this smells like damage control to me.

This is only the beginning. This story is enormous, and is likely to explode sooner than later. Stay tuned.

To support my work on Substack, please purchase my book for yourself or for a friend, and leave a review on Amazon. You can learn about efforts to ban my book here.